Apple, Palantir, Tempus AI Price Targets, November 3 2026
Apple
Apple sells the iPhone, Mac, iPad and Apple Watch, plus services such as the App Store, iCloud and Apple Music. The company is based in Cupertino, California. It reported fiscal fourth-quarter results after the close on Monday, its first under chief executive John Ternus. Revenue came to $114.48 billion, 1.0% above the $113.38 billion consensus. Earnings were $2.10 a share, 5.5% above the $1.99 expected.
What Drove Apple’s Quarter
The iPhone and Mac led the beat. iPhone sales grew 17% to $57.58 billion, and Mac sales grew 24% to $10.79 billion.
Services revenue grew 10% to a record $31.57 billion. Greater China sales came to $17.54 billion, 5.6% below the $18.58 billion estimate. Tariff refunds added about a point to the 47.9% gross margin. For the December quarter, Apple guides to revenue growth of 7% to 10% and a gross margin of 45% to 46%.
Sixteen Desks Move on Apple
William Power of Baird kept Outperform and raised his target from $330 to $340 today, a Tuesday. David Vogt of UBS kept Neutral and raised his target from $296 to $340. Erik Woodring of Morgan Stanley kept Overweight and lowered his target from $355 to $350. Samik Chatterjee of JPMorgan kept Overweight and lowered his target from $360 to $355.
Dan Ives of Yorkville Ives reiterated Outperform with a $400 price target. Amit Daryanani of Evercore ISI reiterated Outperform with a $380 price target. Mark Newman of Bernstein reiterated Outperform with a $370 price target. Ben Reitzes of Melius reiterated Buy with a $370 price target. Brandon Nispel of KeyBanc reiterated Underweight with a $250 price target. Melissa Fairbanks of Raymond James reiterated Market Perform. Warren Lau of Aletheia Capital reiterated Sell with a $250 price target.
Tim Long of Barclays kept Underweight and raised his target from $245 to $261. Jim Kelleher of Argus kept Buy and raised his target from $375 to $400. Gil Luria of DA Davidson kept Neutral and raised his target from $270 to $295. Krish Sankar of TD Cowen kept Buy and lowered his target from $400 to $390. Barton Crockett of Rosenblatt reiterated Neutral with a $303 price target.
Lau wrote: “we expect both gross and operating margins to contract.”
Apple’s Record on AnaChart
Apple draws 26 covering analysts on AnaChart. Their average target is $326.84, with a high of $400 and a low of $245. Ratings split 61.29% Buy, 34.19% Hold and 4.52% Sell. AnaChart’s tracking shows 86.11% of Apple targets get met, after about 309 days on average. Chatterjee has met 119 of his 120 targets on the stock, with an average potential upside of 6.94%. Woodring has met 50 of 57, with an average potential upside of 7.47%.
Palantir
Palantir sells data and AI software to governments and companies, through its Gotham, Foundry and AIP platforms. The company is based in Denver. It reported third-quarter results after the close on Monday. Revenue came to $2.31 billion, 6.5% above the $2.17 billion consensus. Adjusted earnings were $0.44 a share, 7.3% above the $0.41 expected.
What Drove Palantir’s Quarter
U.S. commercial sales drove the beat. They grew 148% to $984 million, passing U.S. government revenue of $953 million for the first time.
Total revenue grew 96%. The adjusted operating margin came to 62%. Palantir raised its 2026 revenue outlook to $8.53 billion to $8.534 billion, from $8.15 billion to $8.158 billion. Chief executive Alex Karp said U.S. commercial revenue “has surpassed our U.S. government revenue for the first time in our company’s history.”
Twelve Desks Weigh In on Palantir
Tyler Radke of Citi kept Buy and raised his target from $250 to $265 today. Clarke Jeffries of Piper Sandler kept Overweight and raised his target from $231 to $235. Sanjit Singh of Morgan Stanley kept Equal Weight and raised his target from $205 to $233.
John McPeake of Rosenblatt reiterated Buy with a $260 price target. Power of Baird reiterated Outperform with a $250 price target. Karl Keirstead of UBS reiterated Buy with a $250 price target. Gregg Moskowitz of Mizuho reiterated Outperform with a $245 price target. Gabriela Borges of Goldman Sachs reiterated Buy with a $235 price target. Thomas Blakey of Cantor Fitzgerald reiterated Neutral with a $207 price target.
Arvind Ramnani of Truist kept Buy and raised his target to $250. Rishi Jaluria of RBC kept Underperform and raised his target from $90 to $130. Luria of DA Davidson reiterated Buy with a $250 price target.
Palantir’s Record on AnaChart
Palantir draws 23 covering analysts on AnaChart. Their average target is $203. Ratings split 62.62% Buy, 26.17% Hold and 11.21% Sell. AnaChart’s tracking shows 69.54% of Palantir targets get met, after about 143 days on average. McPeake has met 3 of his 11 targets on the stock, with an average potential upside of 30.76%.
Tempus AI
Tempus AI runs genomic tests for cancer patients and licenses the resulting clinical data to drug makers. The company is based in Chicago. It reported third-quarter results before the open on Monday. Revenue grew 23% to $411.5 million. Adjusted earnings were $0.07 a share, 600% above the $0.01 consensus.
What Drove Tempus AI’s Quarter
Diagnostics drove the growth. Diagnostics revenue grew 20% to $303.5 million, and oncology test volume grew 32%.
Data and applications revenue grew 33% to $108.1 million. Adjusted EBITDA came to $25.6 million, up from $1.5 million. Tempus raised its 2026 revenue outlook to $1.6 billion to $1.605 billion.
Six Desks Raise Tempus AI
Mark Massaro of BTIG kept Buy and raised his target from $80 to $100 today. Catherine Schulte of Baird kept Outperform and raised her target from $85 to $92. Sarah James of Cantor Fitzgerald kept Overweight and raised her target from $80 to $92. Yi Chen of HC Wainwright kept Buy and raised the target from $68 to $85. Tycho Peterson of Jefferies upgraded Tempus AI to Hold from Underperform and raised the price target from $35 to $70. Gene Mannheimer of Freedom Markets kept Hold and raised his target from $73 to $89.
Tempus AI’s Record on AnaChart
Tempus AI draws 15 covering analysts on AnaChart. Their average target is $73.57. Ratings split 65.96% Buy and 34.04% Hold. AnaChart’s tracking shows 80.41% of Tempus AI targets get met, after about 48 days on average. Massaro has met 5 of his 9 targets on the stock, with an average potential upside of 19.12%.
What the Performance Matrix Shows
Apple has the best met ratio of the three, and Palantir the lowest. A Tempus AI target that gets met lands in about 48 days. An Apple target takes about 309. Power of Baird and Luria of DA Davidson moved on both Apple and Palantir today. AnaChart’s first Palantir forecast dates to October 2020, and its first Tempus AI forecast to July 2024.
AnaChart tracks every price target against what happened to the stock afterward, desk by desk and analyst by analyst. The ticker pages linked above break out each record by analyst, firm and year. AnaChart’s full data set holds more than 760,000 analyst calls on more than 9,000 tickers, active and delisted. More than 680,000 carry a price target and more than 730,000 carry a rating. It is the second largest database of its kind. The raw file is available through the AnaChart store.
The previous update covered Regeneron, AbbVie and Mohawk on November 2.
